ASH 2022 | sciencenewsnet.in

Breaking News

COVID-19-induced financial hardships reveal mental health struggles

Cedars-Sinai Guerin Children’s Expert Reelected to Leadership Position of Pediatric Oncology Organization

Early Alzheimer’s Detection with Artificial Intelligence

AANA Presents U.S. Representative Jen Kiggans With National Health Leadership Award

UC Irvine astronomers’ simulations support dark matter theory

Rensselaer Researcher Publishes Groundbreaking Study on Labor Market Discrimination Against Transgender People

Rutgers New Jersey Medical School Students Tune into the Power of Music

Important update re Annals Embargoed Tip Sheet for 4/30

Semaglutide suitable for people with HIV and fatty liver disease

Competition from “skinny label” generics saved Medicare billions

30 Apr, 2024

Novel Drug Shows Early Promise in Treating Multiple Myeloma

December 11, 2022 sarah JonasResearch Results

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 565).